References and Notes
1
Gustafson K.
Roman M.
Fenical W.
J. Am. Chem. Soc.
1989,
111:
7519
2a
Kim H.-H.
Kim W.-G.
Ryoo I.-J.
Kim C.-J.
Suk J.-E.
Han K.-H.
Hwang S.-Y.
Yoo I.-D.
J. Microbiol. Biotechnol.
1997,
7:
429
2b
Jaruchoktaweechai C.
Suwanborirus K.
Tanasupawatt S.
Kittakoop P.
Menasveta P.
J. Nat. Prod.
2000,
63:
984
2c
Nagao T.
Adachi K.
Sakai M.
Nishijima M.
Sano H.
J. Antibiot.
2001,
54:
333
2d
Romero-Tabarez M.
Jansen R.
Sylla M.
Lünsdorf H.
Häußler S.
Santosa DA.
Timmis KN.
Molinari G.
Antimicrob Agents Chemother.
2006,
50:
1701
For the total synthesis, see:
3a
Smith AB.
Ott GR.
J. Am. Chem. Soc.
1996,
118:
13095
3b
Kim Y.
Singer RA.
Carreira EM.
Angew. Chem. Int. Ed.
1998,
37:
1261
3c
Marino JP.
McClure MS.
Holub DP.
Comasseto JV.
Tucci FC.
J. Am. Chem. Soc.
2001,
124:
1664
For partial syntheses, see:
4a
Benvegnu T.
Schio L.
Le Floch Y.
Grèe R.
Synlett
1994,
505
4b
Donaldson WA.
Bell PT.
Wang Z.
Bennett DW.
Tetrahedron Lett.
1994,
35:
5829
4c
Boyce RJ.
Pattenden G.
Tetrahedron Lett.
1996,
37:
3501
4d
Benvegnu T.
Toupet L.
Greè R.
Tetrahedron
1996,
52:
11811
4e
Benvegnu T.
Greè R.
Tetrahedron
1996,
52:
11821
4f
Prahlad V.
Donaldson WA.
Tetrahedron Lett.
1996,
37:
9169
4g
Gonzàlez A.
Aiguadè J.
Urp F.
Villarasa J.
Tetrahedron Lett.
1996,
37:
8949
4h
Tanimori S.
Morita Y.
Tsubota M.
Nakayama M.
Synth. Commun.
1996,
26:
559
4i
Donaldason WA.
Barmann H.
Prahlad V.
Tao C.
Yun YK.
Wang Z.
Tetrahedron
2000,
56:
2283
4j
Li S.
Xu R.
Bai D.
Tetrahedron Lett.
2000,
41:
3463
4k
Hoffmann HMR.
Vakalopoulos A.
Org. Lett.
2001,
3:
177
4l
Shukun L.
Donaldson WA.
Synthesis
2003,
13:
2064
4m
Fukuda A.
Kobayashi Y.
Kimachi T.
Takemoto Y.
Tetrahedron
2003,
59:
9305
4n
Li S.
Xiao X.
Yan X.
Xu R.
Bai D.
Tetrahedron
2005,
61:
11291
For a total synthesis of an analogue of macrolactin A, see:
4o
Kobayashi Y.
Fukuda A.
Kimachi T.
Ju-ichi M.
Takemoto Y.
Tetrahedron Lett.
2004,
45:
677
4p
Kobayashi Y.
Fukuda A.
Kimachi T.
Ju-ichi M.
Takemoto Y.
Tetrahedron
2005,
61:
2607
5
Bonini C.
Chiummiento L.
Pullez M.
Solladié G.
Colobert F.
J. Org. Chem.
2004,
69:
5015
6 Extensive work on different propargylic alcohols led to a general protocol for the preparation of aromatic and heteroaromatic sulfones as reported in: Bonini C.
Chiummiento L.
Videtta V.
Synlett
2005,
3067
7a
Blakemore PR.
J. Chem. Soc., Perkin Trans. 1
2002,
2563
7b
Baudin JB.
Hareau G.
Julia SA.
Lorne R.
Ruel O.
Bull. Soc. Chim. Fr.
1993,
130:
336
7c
Baudin JB.
Hareau G.
Julia SA.
Lorne R.
Ruel O.
Bull. Soc. Chim. Fr.
1993,
130:
856
7d
Baudin JB.
Hareau G.
Julia SA.
Ruel O.
Tetrahedron Lett.
1991,
32:
1175
8 The stereochemical outcome of the one-pot Julia olefination is generally substrate (sulfone and aldehyde) controlled. Moreover, there are some examples where β,γ-unsaturated BT-sulfones give high levels of E stereoselectivity (see ref. 7a).
9
Bonini C.
Chiummiento L.
Lopardo MT.
Pullez M.
Colobert F.
Solladié G.
Tetrahedron Lett.
2003,
44:
2695
For recent reviews of the alkene metathesis reaction, see:
10a
Nicolaou KC.
Bulger PG.
Sarlah D.
Angew. Chem. Int. Ed.
2005,
44:
4490
10b
Schmidt B.
Hermanns J.
Top. Organomet. Chem.
2004,
7:
223
10c
Fürstner A.
Angew. Chem. Int. Ed.
2000,
39:
3012
10d
Grubbs RH.
Chang S.
Tetrahedron
1998,
54:
4413
11 These high Z selectivities prompted us to study the one-pot Julia olefination with propargylic sulfone 6 and several different aromatic and aliphatic aldehydes more extensively: Bonini C.
Chiummiento L.
Videtta V.
Synlett
2006,
2079
12a
Still WC.
Gennari C.
Tetrahedron Lett.
1983,
24:
4405
12b
Yu W.
Su M.
Tetrahedron Lett.
1999,
40:
6725
13 Attempts were made to prepare the tributyl propargylic phosphorane but we had some problems obtaining it pure.
14 Compound 3
: R
f
0.26 (PE-Et2O-CH2Cl2, 99:2:1). 1H NMR (500 MHz, CDCl3): δ = 7.40 (dd, J
4,5 = 14.4 Hz, J
4,3 = 11.9 Hz, 1 H), 6.55 (t, J
3,2 = J
3,4 = 11.0 Hz, 1 H), 6.18 (dd, J
8,9 = 16.0 Hz, J
8,7 = 5.0 Hz, 1 H), 6.03 (dt, J
5,4 = 15.5 Hz, J
5,6 = 8.0 Hz, 1 H), 5.72 (d, J
9,8 = 16.0 Hz, 1 H), 5.61 (d, J
2,3 = 11.5 Hz, 1 H), 4.26 (m, 1 H), 3.73 (s, 3 H), 2.41 (m, 2 H), 0.89 (s, 9 H), 0.19 (s, 9 H), 0.03 (s, 6 H). 13C NMR (125 MHz, CDCl3): δ = 166.9, 146.4, 145.0, 140.4, 129.2, 115.8, 109.2, 103.3, 95.0, 71.8, 51.1, 41.3, 25.8, 18.1, -0.1, -4.6, -4.9. EI-MS: m/z (%) = 392 (100), 267 (100), 73 (50), 75 (20), 45. Anal. Calcd for C21H36O3Si2: C, 64.23; H, 9.24. Found: C, 64.32; H, 9.18.